EcoDrugPlus

Dihydrofolate Reductase

Ensembl ID : ENSBMUG00000002842
Gene Symbol: DHFR
2 Cross references
348 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSBMUG00000000982
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSBMUG00000003530
Gene Symbol: DPYD
3 Cross references
228 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSBMUG00000017564
Gene Symbol: DPP4
3 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSBMUG00000012414
Gene Symbol: DDR2
3 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSBMUG00000007257
Gene Symbol: DRD1
3 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSBMUG00000012254
Gene Symbol: DRD2
3 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSBMUG00000015995
Gene Symbol: DRD3
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSBMUG00000002637
Gene Symbol: DRD5
3 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSBMUG00000026172
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSBMUG00000020195
Gene Symbol: EGLN1
3 Cross references
239 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSBMUG00000022958
Gene Symbol: EGLN2
3 Cross references
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).